Skip to main content

Table 1 Baseline characteristics of 9 patients included in the study

From: Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility

 

Mean (SD) or N (%)

Gestational age, weeks

39.7 (2.1)

Birth weight, g

3014 (492)

Caesarean delivery

4 (44)

Outborn

8 (89)

Males

4 (44)

5-min Apgar

3.4 (1.8)

10-min Apgar

4.3 (2.2)

Cord blood pH

6.82 (0.16)

Base deficit, mmol/L

23.3 (6.0)

Moderate encephalopathy

7 (78)

Severe encephalopathy

2 (22)

Seizures on admission

0 (0)

Need for mechanical ventilation

9 (100)

Age at admission, hours

1.7 (1.0)

Age at first intervention*, hours

3.9 (0.5)

  1. *Hypothermia combined with erythropoietin and magnesium sulfate infusion